440 filings
Page 10 of 22
8-K
uolp6jppvsb
6 Nov 19
AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results
4:26pm
UPLOAD
hip8obt 20
25 Oct 19
Letter from SEC
12:00am
8-K
aj1w1neomn7c
27 Sep 19
Entry into a Material Definitive Agreement
4:05pm
8-K
fqx gwyvetzas04prdoh
5 Aug 19
AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:10pm
8-K
znb8swm4
25 Jun 19
Amendments to Articles of Incorporation or Bylaws
4:49pm
8-K
60ydjyr340n94m
3 Jun 19
AcelRx announces the closing of a $25 million senior secured debt facility
7:10am
DEFA14A
50iekl2k0 t5i
14 May 19
Additional proxy soliciting materials
6:08am
424B5
ivew2c6cr4oqx738
9 May 19
Prospectus supplement for primary offering
8:55am
8-K
c2yu rnbs
8 May 19
AcelRx Pharmaceuticals Reports First Quarter 2019 Financial Results
4:04pm
PRE 14A
rbd edtldv
3 May 19
Preliminary proxy
5:03pm
S-8
w5hsltfxg35t449vud
7 Mar 19
Registration of securities for employees
5:29pm
8-K
hse72ih6m
7 Mar 19
AcelRx Pharmaceuticals Announces Commercial Launch of DSUVIA and Reports Fourth Quarter and Full Year 2018 Financial Results
4:05pm
8-K
mfyh75t
14 Feb 19
Departure of Directors or Certain Officers
12:00am
8-K
7s9mn5
11 Jan 19
Departure of Directors or Certain Officers
4:31pm